Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.8573
+0.0306 (3.70%)
At close: Sep 9, 2025, 4:00 PM
0.8569
-0.0004 (-0.05%)
After-hours: Sep 9, 2025, 7:54 PM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $84.57 million as of September 9, 2025. Its market cap has decreased by -42.39% in one year.
Market Cap
84.57M
Enterprise Value
28.22M
1-Year Change
-42.39%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since April 17, 2014, Immunic's market cap has decreased from $253.40M to $84.57M, a decrease of -66.62%. That is a compound annual growth rate of -9.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 81.60M | -9.43% |
| Dec 31, 2024 | 90.10M | 33.09% |
| Dec 29, 2023 | 67.70M | 23.09% |
| Dec 30, 2022 | 55.00M | -78.11% |
| Dec 31, 2021 | 251.20M | -20.71% |
| Dec 31, 2020 | 316.80M | 222.94% |
| Dec 31, 2019 | 98.10M | 1,141.77% |
| Dec 31, 2018 | 7.90M | -96.85% |
| Dec 29, 2017 | 251.10M | 80.13% |
| Dec 30, 2016 | 139.40M | -60.23% |
| Dec 31, 2015 | 350.50M | -41.04% |
| Dec 31, 2014 | 594.50M | 134.61% |
| Apr 17, 2014 | 253.40M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |